W E Smith
W E Smith publishes mostly in Pulmonary and Respiratory Medicine, Geriatrics and Gerontology and Cancer Research, on topics such as Pharmaceutical Practices and Patient Outcomes, Occupational and environmental lung diseases and Carcinogens and Genotoxicity Assessment.
- World rank
- #6,286,093 of 7,710,434 ranked researchers
- Rank in United States
- #1,499,414 of 1,627,098
- Works
- 33
- Citations
- 114
- Citations per work
- 3.5
What does W E Smith research?
W E Smith's work is mostly in Medicine (37%), Biochemistry, Genetics and Molecular Biology (6%), Economics, Econometrics and Finance (4%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Everything else1853.8%
- Health Sciences1236.6%
- Medicine1236.6%
- Life Sciences25.8%
- Social Sciences13.8%
- 1Pulmonary and Respiratory Medicine14% of their works
- 2Geriatrics and Gerontology12% of their works
- 3Cancer Research6% of their works
- 4Radiology, Nuclear Medicine and Imaging6% of their works
- 5Pediatrics, Perinatology and Child Health6% of their works
- 6Economics and Econometrics4% of their works
Research topics
- Pharmaceutical Practices and Patient Outcomes
- Occupational and environmental lung diseases
- Carcinogens and Genotoxicity Assessment
- Pharmaceutical studies and practices
- Cancer Research and Treatments
- Cancer therapeutics and mechanisms
- Microbial infections and disease research
- Chemical Safety and Risk Management
Which keywords describe W E Smith's research?
The keywords of their largest research topics: Inappropriate Medication Use, Polypharmacy, Immunotherapy, BAP1 mutations, Malignant Pleural Mesothelioma, Risk Assessment, Comet Assay and Genotoxicity Testing.
- Tumor Targeting
- Pasteurella
- Laboratory Safety
- Chemical Management
- Pediatric Pharmacokinetics
- Genotoxicity Testing
- Risk Assessment
- BAP1 mutations
- Polypharmacy
- Inappropriate Medication Use
- Immunotherapy
- Malignant Pleural Mesothelioma
- Comet Assay
- Off-Label Drug Use
- Bacterial Therapy
- DNA
- Mycoplasma
- Topoisomerases
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 18 words, with their numbers
- Inappropriate Medication Use61 topic
- Polypharmacy61 topic
- Immunotherapy52 topics
- BAP1 mutations41 topic
- Malignant Pleural Mesothelioma41 topic
- Risk Assessment42 topics
- Comet Assay31 topic
- Genotoxicity Testing31 topic
- Off-Label Drug Use31 topic
- Pediatric Pharmacokinetics31 topic
- Bacterial Therapy11 topic
- Chemical Management11 topic
- DNA11 topic
- Laboratory Safety11 topic
- Mycoplasma11 topic
- Pasteurella11 topic
- Topoisomerases11 topic
- Tumor Targeting11 topic
Where does W E Smith work?
W E Smith's main affiliation in the publication record is Northeastern University, United States.
How many publications and citations does W E Smith have?
OpenAlex counts 33 works and 114 citations for W E Smith, an h-index of 6, ranking #6,286,093 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Other researchers named W E Smith
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about W E Smith. Posts are plain text and can be reported.